Please try another search
Fluicell AB (publ) operates as a life science company, provides platforms and research solutions for bioprinting and single-cell biology. The company offers BIOPEN, a microfluidic platform for high-precision single-cell solution delivery that enables to control the cell microenvironment without moving or disturbing the cells; Biozone 6 that generate dose-response curves or study the effects of multiple drug compounds; and Dynaflow Resolve system, an ion channel screening platform, which allows to record various ion channel current in patch-clamp recording configuration. It also provides Biopixlar, a 3D single-cell bioprinting platform that enables high cell viability and cell-to-cell communication; and Biopixlar AER, an easy-to-use 3D bioprinting platform that fits into your fume hood or biosafety cabinet. The company also offers accessory and consumable products for bioprinting and single-cell biology. The company was incorporated in 2012 and is based in Mölndal, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Gavin D. M. Jeffries | 43 | 2012 | CTO & Director |
Daniel T. Chiu | 51 | 2017 | Director |
Michael Olausson | - | - | Member of Scientific Advisory Board |
Regina Fritsche Danielson | - | - | Director |
Carl Fhager | 48 | 2017 | Director |
Stefan Andersson Tilk | 59 | 2016 | Chairman of the Board |
Owe Orwar | 59 | 2015 | Director |
Goran Gannedahl | 70 | - | Member of Scientific Advisory Board |
Astrid Brodd | - | - | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review